The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells

Gynecologic Oncology

Volumn 94, Issue 2, 2004, Pages 283-288

  Santin, Alessandro D ^a,d   Cane', Stefania ^a   Bellone, Stefania ^a   Bignotti, Eliana ^b   Palmieri, Michela ^b   De Las Casas, Luis E ^c   Roman, Juan J ^a   Anfossi, Simone ^a   O'Brien, Timothy ^a   Pecorelli, Sergio ^b  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

ADX; cervical adenocarcinoma; Cervical cancer; CVX; KRT; normal keratinocytes; SCCE; Serine protease; squamous cervical cancer; Stratum Corneum Chymotryptic Enzyme

Indexed keywords

KALLIKREIN; PARAFFIN; SERINE PROTEINASE;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CATALYSIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; METASTASIS; PELVIS LYMPH NODE; PELVIS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN SURFACE; SQUAMOUS CELL CARCINOMA; STRATUM CORNEUM; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM;

ADULT; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; MIDDLE AGED; RABBITS; SERINE ENDOPEPTIDASES; UTERINE CERVICAL NEOPLASMS;

EID: 3543124742     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.05.023     Document Type: Article

References (24)

1. Tryggvason K., Hoyhtya M., Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim. Biophys. Acta. 907:1987;191-207
2. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64:1991;327-336
3. Duffy M.J. The role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Metastasis. 10:1992;145-155
4. Hooper J.D., Clements J.A., Quigley J.P., Antalis T.M. Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J. Biol. Chem. 276:2001;857-860
5. Diamandis E.P., Yousef G.M. Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem. 48:2002;1198-1205
6. Tanimoto H., Underwood L.J., Shigemasa K., Parmley T.H., O'Brien T.J. Increased expression of protease M in ovarian tumors. Tumour Biol. 22:2001;11-18
7. Tanimoto H., Underwood L.J., Shigemasa K., Yan Yan M.S., Clarke J., Parmley T.H., et al. The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer. 86:1999;2074-2082
8. Underwood L.J., Shigemasa K., Tanimoto H., Beard J.B., Schneider E.N., Wang Y., et al. Ovarian tumor cells express a novel multi-domain cell surface serine protease. Biochim. Biophys. Acta. 1502:2000;337-350
9. Underwood L.J., Tanimoto H., Wang Y., Shigemasa K., Parmley T.H., O'Brien T.J. Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res. 59:1999;4435-4439
10. Tanimoto H., Underwood L.J., Wang Y., Shigemasa K., Parmley T.H., O'Brien T.J. Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention. Tumour Biol. 22:2001;104-114
11. Hansson L., Strömqvist M., Bäckman A., Wallbrandt P., Carlstein A., Egelrud T. Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. J. Biol. Chem. 269:1994;19420-19426
12. Brattsand M., Egelrud T. Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J. Biol. Chem. 274:1999;30033-30040
13. Santin A.D., Hermonat P.L., Ravaggi A., Chiriva-Internati M., Zhan D., Pecorelli S., et al. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. J. Virol. 73:1999;5402-5410
14. Stephan C., Jung K., Diamandis E.P., Rittenhouse H.G., Lein M., Loening S.A. Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer. Urology. 59:2002;2-8
15. Yousef G.M., Polymeris M.E., Grass L., Soosaipillai A., Chan P.C., Scorilas A., et al. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Res. 63:2003;3958-3965
16. Diamandis E.P., Scorilas A., Fracchioli S., Van Gramberen M., De Bruijn H., Henrik A., et al. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J. Clin. Oncol. 21:2003;1035-1043
17. Bharaj B.B., Luo L.Y., Jung K., Stephan C., Diamandis E.P. Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers. Prostate. 51:2002;35-41
18. Diamandis E.P., Okui A., Mitsui S., Luo L.Y., Soosaipillai A., Grass L., et al. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res. 62:2002;295-300
19. Luo L.Y., Katsaros D., Scorilas A., Fracchioli S., Bellino R., van Gramberen M., et al. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res. 63:2003;807-811
20. Yousef G.M., Fracchioli S., Scorilas A., Borgono C.A., Iskander L., Puopolo M., et al. Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer. Am. J. Clin. Pathol. 119:2003;346-355
21. Steinman R.M., Pope M. Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 109:2002;1519-1526
22. Cannon M.J., O'Brien T.J., Underwood L.J., Crew M.D., Bondurant K.L., Santin A.D. Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer. Expert Rev. Anticancer Ther. 2:2002;97-105
23. Heiser A., Coleman D., Dannull J., Yancey D., Maurice M.A., Lallas C.D., et al. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J. Clin. Invest. 109:2002;409-417
24. Nouri-Shirazi M., Banchereau J., Bell D., Burkeholder S., Kraus E.T., Davoust J., et al. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J. Immunol. 165:2000;3797-3803